Home > Insider Trading > Filing (0001415889-22-002740)

Filing Details

Accession Number:: 0001415889-22-002740
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-08 16:06:06
Reporting Period:: 2022-03-03

Accepted Time:: 2022-03-08 16:06:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1597264	Blueprint Medicines Corp	BPMC	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1638474	W. Jeffrey Albers	C/O Blueprint Medicines Corporation 45 Sidney Street Cambridge MA 02139	Ceo And President	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2022-03-03	7,862	$60.28	188,086	No	4	S	Direct
Common Stock	Acquisiton	2022-03-04	7,500	$1.87	195,586	No	4	M	Direct
Common Stock	Acquisiton	2022-03-04	12,500	$15.01	208,086	No	4	M	Direct
Common Stock	Disposition	2022-03-04	10,055	$56.61	198,031	No	4	S	Direct
Common Stock	Disposition	2022-03-04	4,445	$57.66	193,586	No	4	S	Direct
Common Stock	Disposition	2022-03-04	4,100	$58.28	189,486	No	4	S	Direct
Common Stock	Disposition	2022-03-04	1,400	$59.43	188,086	No	4	S	Direct
Common Stock	Disposition	2022-03-07	4,843	$56.19	183,243	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2022-03-04	7,500	$0.00	7,500	$1.87
Common Stock	Stock Option (Right to Buy)	Disposition	2022-03-04	12,500	$0.00	12,500	$15.01

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
127,903		2024-07-30	No	4	M	Direct
65,000		2026-02-03	No	4	M	Direct

Footnotes

The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with thevesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Effected pursuant to a trading plan adopted on January 11, 2021 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $56.03 to $57.01 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $57.04 to $58.01 per share.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $58.05 to $58.63 per share.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $59.10 to $59.89 per share.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $56.18 to $56.90 per share.
This option was granted on July 30, 2014 and is fully vested as of the date hereof.
This option was granted on February 3, 2016 and is fully vested as of the date hereof.